The prevention of type 2 diabetes mellitus

Clinical Medicine

Volumn 3, Issue 5, 2003, Pages 470-474

  Davies, Melanie J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acarbose; Cardiovascular mortality; Diet; Impaired glucose tolerance; Metformin; Obesity; Physical activity; Prevention; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; TETRAHYDROLIPSTATIN; TROGLITAZONE;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIETARY INTAKE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; RISK FACTOR; UNITED KINGDOM;

EID: 0142228978     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-5-470     Document Type: Conference Paper

References (29)

1. McCarty D, Zimmet P. Diabetes 1994 to 2010: global estimates and projections. Melbourne: International Diabetes Institute, 1994.
2. Kohner EM, Aldington SJ, Stratton IM, Manley SE et al. UKPDS 30; diabetic retinopathy at diagnosis of non-insulin dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
3. The UKPDS Study Group. Overview of 6 years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study 16. Diabetes 1995;44:1249-58.
4. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
5. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
6. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998;101:497-504.
7. Consensus statement from American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23:381-9.
8. Marshall JA, Hamman RF, Baxter J. High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol 1991;134:590-603.
9. Fung TT, Hu FB, Pereira MA, Liu S et al. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am Soc Clin Nut 2002;76:535-40.
10. Sargeant LA, Khaw KT, Bingham S, Day NE et al. Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study. Eur J Clin Nut 2001;55:342-8.
11. Lowry R, Wechsler H, Kann L, Collins JL. Recent trends in participation in physical education among US high school students. J School Health 2001;71:145-52.
12. McKinlay J, Marceau L. US public health and the 21st century: diabetes mellitus. Lancet 2000;356:757-61.
13. Puska P, Tuomilehto J, Salonen J, Neittaanmaki L et al. Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular disease (North Karelia Project). BMJ 1979;2:1173-8.
14. Salonen JT, Puska P, Mustaniemi H. Changes in morbidity and mortality during comprehensive community programme to control cardiovascular disease during 1972-77 in North Karelia. BMJ 1979;2:1178-83.
15. Forster JL, Jeffery RW, Schmid TL, Kramer FM. Preventing weight gain in adults: a pound of prevention. Health Psychol 1988;7:515-25.
16. Egger G, Bolton A, O'Neill M, Freeman D. Effectiveness of an abdominal obesity reduction programme in men: the GutBuster 'waist loss' programme. Int J Obes Relat Metab Disord 1996;20:227-31.
17. Harris MJ, Flegal KM, Cowie CC, Eberhardt MS et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1999;21:518-28.
18. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998;317:371-5.
19. Pan XR, Li GW, Hu YH, Wang JX et al. The Da Qing IGT and Diabetes Study. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997;20:537-44.
20. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT et al. Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
21. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
22. Chiasson J-L. Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M for The STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-7.
23. Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC. The Fasting Hyperglycaemia Study Group. The Fasting Hyperglycaemia Study: II. Randomised controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 1997;46(suppl 1):50-5.
24. Holman RR, Blackwell L, Stratton IM, Manley SE et al. Six year results from the Early Diabetes Intervention Trial. Diabet Med 2003;20 (suppl 2):15.
25. Swinburn BA, Metcalf PA, Ley SJ. Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 2001;24:619-24.
26. Buchanan TA, Xiang AH, Peters RK, Kjos SL et al. Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002;51:2796-803.
27. Sjostrom L, Torgerson JS, Hauptman J, Boldrin M. XENDOS (XENical in the prevention of Diabetes in Obese Subjects): a landmark study. Ninth International Congress on Obesity, 2002, Sao Paulo, Brazil.
28. Kearney JM, de Graaf C, Damkjaer S, Endstrom LM. Stages of change towards physical activity in nationally representative sample in the European Union. Public Health Nutr 1999;2:115-24.
29. Sjostrom CD, Lissner L, Wedel H, Sjostrum L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477-84.